Position in HLN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$15,861,000
+$1,847,000 QoQ
Shares Held
1,700,000
+21.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
4.36%
of 13F equity value
Holder Rank
#39
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CLARK ESTATES INC/NY holds $22,372,537 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (70.9% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,861,000 | 1,700,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $14,014,000 | 1,400,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $18,198,000 | 1,800,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,146,000 | 1,800,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $18,666,000 | 1,800,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $20,580,000 | 2,000,000 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $19,080,000 | 2,000,000 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $21,160,000 | 2,000,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,889,000 | 2,650,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $22,498,500 | 2,650,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $21,809,500 | 2,650,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $23,740,500 | 2,850,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,978,000 | 3,100,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $25,234,000 | 3,100,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,800,000 | 3,100,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $17,356,500 | 2,850,000 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||